Roberts Glore & CO Inc Johnson & Johnson Transaction History

Roberts Glore & CO Inc

  • $341 Million
  • Q3 2024

A detailed history of Roberts Glore & CO Inc transactions in Johnson & Johnson stock. As of the latest transaction made, Roberts Glore & CO Inc holds 57,973 shares of JNJ stock, worth $8.41 Million. This represents 2.76% of its overall portfolio holdings.

Number of Shares
57,973
Previous 58,578 1.03%
Holding current value
$8.41 Million
Previous $8.56 Million 9.74%
% of portfolio
2.76%
Previous 2.61%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024
SELL
$145.48 - $167.38 $88,015 - $101,264
-605 Reduced 1.03%
57,973 $9.4 Million
Q2 2024

Aug 14, 2024
BUY
$144.38 - $157.78 $69,446 - $75,892
481 Added 0.83%
58,578 $8.56 Million
Q1 2024

May 09, 2024
SELL
$155.22 - $162.74 $330,308 - $346,310
-2,128 Reduced 3.53%
58,097 $9.19 Million
Q4 2023

Feb 12, 2024
SELL
$145.6 - $158.88 $27,081 - $29,551
-186 Reduced 0.31%
60,225 $9.44 Million
Q3 2023

Nov 13, 2023
SELL
$155.75 - $174.48 $82,080 - $91,950
-527 Reduced 0.86%
60,411 $9.41 Million
Q2 2023

Aug 14, 2023
SELL
$154.35 - $166.11 $63,283 - $68,105
-410 Reduced 0.67%
60,938 $10.1 Million
Q1 2023

May 08, 2023
SELL
$151.05 - $180.26 $21,902 - $26,137
-145 Reduced 0.24%
61,348 $9.51 Million
Q4 2022

Feb 13, 2023
SELL
$160.2 - $179.79 $726,667 - $815,527
-4,536 Reduced 6.87%
61,493 $10.9 Million
Q3 2022

Nov 07, 2022
SELL
$161.33 - $179.52 $178,914 - $199,087
-1,109 Reduced 1.65%
66,029 $10.8 Million
Q2 2022

Aug 11, 2022
SELL
$168.19 - $186.01 $181,645 - $200,890
-1,080 Reduced 1.58%
67,138 $11.9 Million
Q1 2022

May 02, 2022
SELL
$158.14 - $179.59 $47,600 - $54,056
-301 Reduced 0.44%
68,218 $12.1 Million
Q4 2021

Feb 11, 2022
BUY
$155.93 - $173.01 $73,910 - $82,006
474 Added 0.7%
68,519 $11.7 Million
Q3 2021

Nov 12, 2021
SELL
$161.5 - $179.47 $31,331 - $34,817
-194 Reduced 0.28%
68,045 $11 Million
Q2 2021

Aug 10, 2021
SELL
$159.48 - $171.07 $167,454 - $179,623
-1,050 Reduced 1.52%
68,239 $11.2 Million
Q1 2021

May 06, 2021
SELL
$153.07 - $170.48 $150,620 - $167,752
-984 Reduced 1.4%
69,289 $11.4 Million
Q4 2020

Feb 09, 2021
BUY
$137.11 - $157.38 $41,407 - $47,528
302 Added 0.43%
70,273 $11.1 Million
Q3 2020

Nov 06, 2020
BUY
$140.38 - $153.83 $205,095 - $224,745
1,461 Added 2.13%
69,971 $10.4 Million
Q2 2020

Aug 13, 2020
SELL
$128.81 - $155.51 $1.21 Million - $1.46 Million
-9,402 Reduced 12.07%
68,510 $9.63 Million
Q1 2020

May 11, 2020
BUY
$111.14 - $153.99 $27,229 - $37,727
245 Added 0.32%
77,912 $10.2 Million
Q4 2019

Feb 13, 2020
BUY
$127.5 - $146.44 $3.48 Million - $3.99 Million
27,276 Added 54.13%
77,667 $11.3 Million
Q3 2019

Nov 08, 2019
SELL
$126.95 - $142.14 $112,985 - $126,504
-890 Reduced 1.74%
50,391 $6.52 Million
Q2 2019

Aug 09, 2019
SELL
$131.15 - $144.24 $97,313 - $107,026
-742 Reduced 1.43%
51,281 $7.14 Million
Q1 2019

May 14, 2019
SELL
$125.72 - $139.79 $2,514 - $2,795
-20 Reduced 0.04%
52,023 $7.27 Million
Q4 2018

Feb 08, 2019
SELL
$122.84 - $147.84 $225,779 - $271,729
-1,838 Reduced 3.41%
52,043 $6.72 Million
Q3 2018

Nov 09, 2018
BUY
$121.58 - $142.88 $190,272 - $223,607
1,565 Added 2.99%
53,881 $7.45 Million
Q2 2018

Aug 10, 2018
SELL
$119.4 - $131.76 $170,145 - $187,758
-1,425 Reduced 2.65%
52,316 $6.35 Million
Q1 2018

May 08, 2018
BUY
$125.1 - $148.14 $13,010 - $15,406
104 Added 0.19%
53,741 $6.89 Million
Q4 2017

Feb 09, 2018
SELL
$131.22 - $143.62 $78,338 - $85,741
-597 Reduced 1.1%
53,637 $7.49 Million
Q3 2017

Nov 08, 2017
SELL
$129.47 - $135.38 $70,561 - $73,782
-545 Reduced 0.99%
54,234 $7.05 Million
Q2 2017

Aug 15, 2017
BUY
N/A
54,779
54,779 $7.25 Million

Others Institutions Holding JNJ

# of Institutions
4,275
Shares Held
1.68B
Call Options Held
17.6M
Put Options Held
14.5M
View Full List

About JOHNSON & JOHNSON

JNJ Quotes by TradingView
  • Ticker JNJ
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,614,479,872
  • Market Cap $379B
  • Description
  • Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...
More about JNJ
Track This Portfolio

Track Roberts Glore & CO Inc Portfolio

Follow Roberts Glore & CO Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Roberts Glore & CO Inc , based on Form 13F filings with the SEC.

News

Stay updated on Roberts Glore & CO Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email